key: cord-0871436-bnxeopbv authors: Zhang, Chunmao; Guo, Zhendong; Zhao, Zongzheng; Wang, Tiecheng; Li, Liang; Miao, Faming; Zhang, Cheng; Li, Yuanguo; Gao, Yuwei title: SARS-CoV-2 Aerosol Exhaled by Experimentally Infected Cynomolgus Monkeys date: 2021-07-03 journal: Emerg Infect Dis DOI: 10.3201/eid2707.203948 sha: 8b7c4f0fd852639770c4481fbcb1e0291117358c doc_id: 871436 cord_uid: bnxeopbv We analyzed size of severe acute respiratory coronavirus 2 (SARS-CoV-2) aerosol particles shed by experimentally infected cynomolgus monkeys. Most exhaled particles were small, and virus was mainly released early during infection. By postinfection day 6, no virus was detected in breath, but air in the isolator contained large quantities of aerosolized virus. A lthough airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been proven possible among humans (1), cats (2), ferrets (3) , and Syrian hamsters (4), the relative roles of droplets and aerosols in the airborne transmission of SARS-CoV-2 remain controversial. A recent study showed that coronavirus disease (COVID-19) patients exhaled millions of SARS-CoV-2 particles during early infection stages (5) . However, the size distribution of SARS-CoV-2 aerosol particles in exhaled breath of COVID-19 patients is not clear. To analyze size distribution of SARS-CoV-2 aerosols shed by cynomolgus monkeys, we inoculated 3 monkeys with SARS-CoV-2 via a combination of intranasal, intratracheal, and ocular routes. Monkeys were kept in individual cages placed in an isolator (biosafety housing with HEPA filters and independent ventilation system). The exhaled breath and air in the isolator were collected by a 6-stage Andersen sampler (https://tisch-env.com) at postinfection days 2, 4, and 6, and we quantified the viral RNA copies in samples (Appendix, https://wwwnc.cdc.gov/ EID/article/27/7/20-3948-App1.pdf). We also determined size distribution of SARS-CoV-2 particles. The virus particles monkeys exhaled peaked at postinfection day 2 and ranged from 11,578 to 28,336 RNA copies during a 40-minute period. Tables 1, 2) . For exhaled breath, virus particles in each of the 3 size bins accounted for 27.4%, 49.6%, and 23.0% of the total virus copies/40 min, respectively; for air in the isolator, virus particles in each of the 3 size bins accounted for 3.8%, 75.0%, and 21.2% of the total virus copies/30 min, respectively (Appendix Tables 1, 2, Figure 3 ). Most virus particles were in the smaller particle size range (0.65-4.7 mm), accounting for 77% to 79% of the total virus particles shed by the monkeys; droplets (>4.7 mm) accounted for ≈21%-23% (Appendix Tables 1, 2, Figure 3 ). We tried to isolate live virus by sequentially passaging We analyzed size of severe acute respiratory coronavirus these samples in Vero-E6 cells 3 times (Appendix) but obtained no live virus and observed no cytopathic effects; the reasons for this failure are unknown. The World Health Organization cites the 2 main transmission routes of SARS-CoV-2 as large respiratory droplets and contact transmission. However, we found that monkeys infected with SARS-CoV-2 emitted large quantities of virus aerosol particles, most of which were smaller (<4.7 µm). Ma et al. showed that COVID-19 patients exhaled millions of SARS-CoV-2 particles/hour (5), far more than that noted for monkeys. This variation may result from biological differences between humans and monkeys and different sampling methods. Respiration is much slower in monkeys (2.4 L/min) than in humans (12 L/min). In addition, during sampling, monkeys were anesthetized and breathed slowly through their nostrils, possibly emitting fewer virus particles than when awake. The size of airborne particles determines how the virus is transmitted. Droplets (>4.7 µm) can travel limited distances; smaller particles (<4.7 µm) stay airborne longer and spread widely (6, 7) . Our findings suggest that aerosol transmission might contribute to SARS-CoV-2 spread. Personal protection requires wearing face masks, maintaining social distancing, and reducing gatherings. Infection risk in enclosed spaces is lowered by natural wind or mechanical airflow ventilation. Cynomolgus monkeys infected with SARS-CoV-2 emitted most virus particles in early infection stages; particles decreased substantially at postinfection day 6. Zhou et al. demonstrated that COVID-19 patients emitted fewer virus particles when they were recovering and ready for discharge than did those in early infection stages (8) . At postinfection day 6, no virus was detected in the breath of monkeys, but air in the isolator housing the monkeys still contained large quantities of aerosolized virus. These different seemingly noncoherent observations can be attributed to monkey activity, air flow, and some virus aerosol residues exhaled by monkeys for a relatively long period before sampling. Recently, Asadi et al. showed that aerosolized fomites (microscopic particles) played a role in influenza virus transmission between guinea pigs (9) . SARS-CoV-2 may be carried and transmitted between humans by aerosolized fomites. Most SARS-CoV-2 aerosol particles exhaled by the cynomolgus monkeys in this study were smaller, suggesting that aerosols might be a route for SARS-CoV-2 transmission. Drs. Chunmao Zhang, Guo, and Zhao are investigators at the Military Veterinary Research Institute. Their primary interests are pathogenicity and airborne transmissibility of respiratory viruses, especially influenza viruses. Consideration of the aerosol transmission for COVID-19 and public health Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2 Infection and rapid transmission of SARS-CoV-2 in ferrets Pathogenesis and transmission of SARS-CoV-2 in golden hamsters Coronavirus disease 2019 patients in earlier stages exhaled millions of severe acute respiratory syndrome coronavirus 2 per hour Exposure to influenza virus aerosols during routine patient care Transmission of influenza A in human beings Breath-, air-and surface-borne SARS-CoV-2 in hospitals Influenza A virus is transmissible via aerosolized fomites All family members had signs and symptoms of COVID-19, the illness caused by SARS-CoV-2 infection. High temperature (37.5°C-38.5°C), coughing, anosmia, and ageusia developed in the mother, who was 54 years of age We thank the staff at the Biosafety Level 3 laboratories of Military Veterinary Research Institute for their support and help.